Figure S1. Ranking the effectiveness of the interventions. A histogram plot showing the ranking probability on the effectiveness of the treatment. This was performed by using the point estimates and standard errors. SP=Sulfadoxine-Pyrimethamine, CQ = Chloroquine, MQ = Mefloquine, PG = Proguanil, PM = Pyrimethamine, PL = Placebo, MQAS = Mefloquine-Artesunate, SPAQ = Sulfadoxine Pyrimethamine-Amodiaquine. (DOCX 28 kb
Individual haemoglobin profiles of patients in the AS group with âĽ10% reduction after day 7, n =10...
Table S1. Sample search strategy for MEDLINE. Table S2. The reason for excluding studies. Table S3. ...
Table S1. Adverse events reported during post-MDA surveys (active detection) and at health facilitie...
Additional file 3: Table S2. Baseline characteristics of patients in the analysis of haematological ...
Table S1. P. berghei - An. gambiae dataset. Data from the laboratory experiment with An. gambiae and...
Additional file 7: Table S11. Adverse events with frequency higher than 3% in the ASMQ + Pq arm (n t...
Examples of interpretable piperaquine concentration-inhibition curves (Panel A) and non-interpretabl...
Table S1. Demographics of study participants. Table S2. Adverse events reported in study participant...
Meta-analysis of per patient efficacy of cryotherapy compared to pentavalent antimonials (intent to ...
Figure S1. Correlation between RFUs and the log-concentrations of thymoquinone (nM) on Babesia and T...
Table S1. Reactions modified to curate the Plasmodium falciparum genome-scale metabolic model. (ST2A...
Figure S1. Capillary whole blood piperaquine concentrations at day 7 post-dose, stratified by self-r...
Methaemoglobin concentration over time, expressed as the % of total haemoglobin. Within the G6PDn gr...
Additional file 6. Meta-regression of PCR-unadjusted treatment failure at day 28, association betwee...
Supplementary methods. Treatment guidelines, demographic data collection, and laboratory protocols. ...
Individual haemoglobin profiles of patients in the AS group with âĽ10% reduction after day 7, n =10...
Table S1. Sample search strategy for MEDLINE. Table S2. The reason for excluding studies. Table S3. ...
Table S1. Adverse events reported during post-MDA surveys (active detection) and at health facilitie...
Additional file 3: Table S2. Baseline characteristics of patients in the analysis of haematological ...
Table S1. P. berghei - An. gambiae dataset. Data from the laboratory experiment with An. gambiae and...
Additional file 7: Table S11. Adverse events with frequency higher than 3% in the ASMQ + Pq arm (n t...
Examples of interpretable piperaquine concentration-inhibition curves (Panel A) and non-interpretabl...
Table S1. Demographics of study participants. Table S2. Adverse events reported in study participant...
Meta-analysis of per patient efficacy of cryotherapy compared to pentavalent antimonials (intent to ...
Figure S1. Correlation between RFUs and the log-concentrations of thymoquinone (nM) on Babesia and T...
Table S1. Reactions modified to curate the Plasmodium falciparum genome-scale metabolic model. (ST2A...
Figure S1. Capillary whole blood piperaquine concentrations at day 7 post-dose, stratified by self-r...
Methaemoglobin concentration over time, expressed as the % of total haemoglobin. Within the G6PDn gr...
Additional file 6. Meta-regression of PCR-unadjusted treatment failure at day 28, association betwee...
Supplementary methods. Treatment guidelines, demographic data collection, and laboratory protocols. ...
Individual haemoglobin profiles of patients in the AS group with âĽ10% reduction after day 7, n =10...
Table S1. Sample search strategy for MEDLINE. Table S2. The reason for excluding studies. Table S3. ...
Table S1. Adverse events reported during post-MDA surveys (active detection) and at health facilitie...